Serum levels of cefuroxime can be reduced by haemodialysis or peritoneal dialysis.
Cefuroxime may also be used for purposes not listed in this medication guide.
Cefuroxime is excreted by glomerular filtration and tubular secretion.
Tell your doctor if you experience serious side effects of Ceftin including watery or bloody diarrhea, fever, chills, body aches, flu symptoms, chest pain, fast or pounding heartbeats, unusual bleeding, blood in your urine or dark colored urine, seizure convulsions , confusion, weakness, jaundice yellowing of the skin or eyes , severe blistering peeling red skin rash, bruising, severe tingling, numbness, pain, muscle weakness, increased thirst, loss of appetite, swelling, weight gain, shortness of breath, painful or difficult urination, or urinating less than usual or not at all.
Shake the bottle to loosen the powder. When available, the clinical microbiology laboratory should provide the results of in vitro susceptibility tests for antimicrobial drug products used in local hospitals and practice areas to the physician as periodic reports that describe the susceptibility profile of nosocomial and community-acquired pathogens.
Administer CEFTIN at least 1 hour before or 2 hours after administration of short-acting antacids. Surgical prophylaxis for gastrointestinal, gynaecological surgery including caesarean section and orthopaedic operations. Determination of blood plasma glucose levels Please refer to section 4. Cefuroxime cefuroxime cefuroxime injection injection for Injection USP and Dextrose Injection USP is a sterile, nonpyrogenic, single use, packaged combination of Cefuroxime Sodium USP crystalline and Dextrose Injection USP diluent in the DUPLEX sterile container.
Widely distributed to body tissues and fluids, including cerebrospinal fluid CSF.
Ask your doctor before use if you are taking the following medications:
However, some factors can increase your risk because they can affect kidney and liver function.
However, the data did provide information necessary to estimate the incidence of agranulocytosis as well as the effects of several potential risk factors.
Constipation Vision problems Inability to focus or speak clearly Chest pain Shortness of breath Heart problems Worsening of seizures.
People with low body weight may have a higher risk of side effects, such as nausea and vomiting.
It can be harmful for people to take this medication if their doctor has not prescribed it. Shake the liquid well just before you measure a dose. Tablets contain the inactive ingredients colloidal silicon dioxide, croscarmellose sodium, hydrogenated vegetable oil, hypromellose, methylparaben, microcrystalline cellulose, propylene glycol, propylparaben, sodium benzoate, sodium lauryl sulfate, and titanium dioxide.